Director, GPS Strategic Distributor Relations & Governance Director at Gilead Sciences

Uxbridge, England, United Kingdom

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, Biotechnology, HealthcareIndustries

Requirements

Bachelor’s degree in Business Administration, Life Sciences, or a related field; advanced degree preferred
Experience in distributor management, contract administration, or equivalent roles within pharmaceutical, healthcare, or regulated industries
Solid experience working in global functions, influencing above-country stakeholders and aligning regional strategies
Highly organized, strategic, and proactive mindset

Responsibilities

Design and implement a comprehensive 3-year Distributor Strategy for GPS distributor markets, ensuring alignment with Regional ICR, guiding optimization, performance targets, and market-specific initiatives (e.g., LATAM, Africa, Middle East, Asia)
Assist Regional Commercial Leads in maintaining and strengthening relationships with distributors, addressing and resolving relationship and performance issues
Oversee end-to-end processes for contracting new distributors, onboarding into company systems, and managing offboarding, ensuring compliance with governance policies and regulations
Lead cross-functional teams (legal, compliance, commercial, finance) in contracting projects, tracking milestones, and ensuring efficient onboarding and offboarding
Organize and facilitate regular governance meetings (monthly, quarterly, steering committees), prepare agendas, track action items, and ensure alignment with policies and standards
Support and coordinate the development of training programs to enhance distributor capabilities and operational excellence, conducting or facilitating regular training sessions
Drive the consistent application of governance standards across regions, developing regional governance frameworks with standardized procedures and documentation
Collaborate closely with Global ICR teams, Regional Commercial Leads, cross-functional teams, and external stakeholders to facilitate seamless operations, compliance, and development initiatives

Skills

Strategic Planning

Distributor Relations

Governance

Compliance

Stakeholder Management

Partnership Development

Cross-Functional Collaboration

Framework Implementation

Regional Operations

Gilead Sciences

Develops and commercializes biopharmaceuticals

About Gilead Sciences

Gilead Sciences focuses on discovering, developing, and commercializing medicines for various medical conditions, including HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular issues. The company conducts extensive research and development to create new therapies, which are then marketed to healthcare providers, hospitals, and pharmacies after receiving regulatory approval. Gilead differentiates itself from competitors through its strong commitment to R&D and strategic partnerships, such as with SAP Ariba, to enhance its operations and product offerings. The company's goal is to improve health equity and access to care globally, working with communities to ensure that its medicines reach those in need.

Foster City, CaliforniaHeadquarters

1987Year Founded

$15,873.6MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Paid family time off and paid parental time off

Generous 401(k) contribution matching

Comprehensive medical plans that cover both physical and mental healthcare

Global Wellbeing Reimbursement

Time Off

Global Volunteer Day

Giving Together Program

Employee Support Programs

Flexible Work Options

Risks

Increased competition in HIV treatment from ViiV Healthcare's expanding drug portfolio.

Regulatory scrutiny over drug pricing could impact Gilead's U.S. market operations.

Patent expirations, like Truvada's, lead to increased generic competition and revenue loss.

Differentiation

Gilead's lenacapavir is recognized as the 2024 Breakthrough of the Year for HIV care.

Partnerships with LEO Pharma and Tubulis enhance Gilead's focus on inflammatory and cancer therapies.

Gilead's commitment to health equity initiatives like COMPASS and HepConnect sets it apart.

Upsides

Gilead's strategic partnerships expand its reach in inflammatory and oncology drug markets.

Investment in digital health technologies enhances Gilead's R&D and patient engagement.

Focus on sustainability improves Gilead's operational efficiency and corporate reputation.

Land your dream remote job 3x faster with AI

Try Jobo Free